Cardiovascular
pharmacology and ophthalmology
- Contribution
to laboratory animal ocular adverse effects interpretation
- Contribution
to interpretation of laboratory animal cardiac morphology and function
- Assessment of
relevance for human species and related clinical risk
- Laboratory
animal ocular examination
|
|
Toxicology,
safety pharmacology
- Advices to
project teams regarding toxicity studies strategy and challenges
- CRO
assessment, selection and monitoring
- Data
interpretation and writing
- DEREK in silico prediction.
- Preliminary
study implementation and performance. For example MPF selection.
- Regulatory study design, implementation and monitoring
Preclinical
efficacy and safety assessment.
- Toxicology, design & interpretation of non-clinical safety aspects
of drug development
- Project & program management
- Regulatory NCD knowledge and official document writing (IMPD, IND)
|
|
|
